Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), a naturally occurring hormone in the body. Its primary function is to stimulate the pituitary gland to produce and release growth hormone. Weight fluctuations during sermorelin therapy are a subject of interest, with some individuals reporting changes in body composition. The potential for increased muscle mass and reduced body fat, which are anticipated effects of elevated growth hormone levels, could indirectly influence weight.
Understanding the effects on body mass is significant due to the implications for metabolic health and overall well-being. Historically, growth hormone-related therapies have been associated with both positive and negative effects on body composition. Careful monitoring of weight and body composition is therefore essential when considering or undergoing sermorelin treatment. The potential benefits include improved energy levels and an increased sense of vitality, often associated with a healthier body composition profile.